Royce & Associates’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-344,346
Closed -$5.28M 779
2025
Q2
$5.28M Sell
344,346
-21,170
-6% -$357K 0.05% 450
2025
Q1
$7.13M Buy
365,516
+74,670
+26% +$2.07M 0.08% 378
2024
Q4
$8.99M Buy
+290,846
New +$7.96M 0.08% 351
2024
Q1
Sell
-103,400
Closed -$8.05M 886
2023
Q4
$8.05M Buy
+103,400
New +$6.4M 0.07% 377

Other funds holding DAVA

Royce & Associates's DAVA Position: Q3 2025 in Review

Royce & Associates sold out of Endava (DAVA) in Q3 2025, closing a stake of 344,346 shares — an estimated $5.28M sold.

Royce & Associates first reported a position in DAVA in Q4 2023 and held it in 4 quarters. The position peaked at $8.99M in Q4 2024. 118 funds tracked by Wall St. Rank hold DAVA as of Q3 2025.

  • Royce & Associates reported no remaining Endava position as of Q3 2025 after selling out during the quarter.
  • Royce & Associates sold 344,346 Endava shares in Q3 2025, an estimated $5.28M.
  • Royce & Associates first reported a position in Endava in Q4 2023 and held it in 4 quarters.
  • Royce & Associates's Endava position peaked at $8.99M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Endava as of Q3 2025.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.